The bioavailability of desogestrel/ethinyl estradiol tablets relative to the oral solution

Clinical Drug Investigation

Volumn 15, Issue 6, 1998, Pages 507-514

  Hunt, Thomas ^a,b   Geetha, Ranga ^a   Warga, Eugene ^a  

^a Pharmaco LSR   (United States)

^b PPD Pharmaco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; TABLET; VAGINA BLEEDING;

EID: 0031837239     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199815060-00007     Document Type: Article

References (4)

1. Mashchak CA, Lobo RA, Dozono-Takano R, et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982; 144: 511-8
2. van Beek AAM, Hageluken CCM, Roes CB. A randomized, group comparative, double blind, placebo-controlled study of the pharmacodynamic effect of 10 μg ethinyl estradiol in the tablet free period of a low-dose oral contraceptive. 1993: Data on file
3. Gibaldt M, Perrier D, editors. Pharmacokinetics. 2nd ed. News York: Marcel Dekker, 1982: 445-9
4. Winter MH, Koda-Kimble M, Young LY, editors. Basic clinical pharmacokinetics. 3rd ed. Washington: Applied Therapeutics, 1994: 2-3